BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 26812610)

  • 1. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
    Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
    Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S
    Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
    Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.
    Khuroo T; Verma D; Talegaonkar S; Padhi S; Panda AK; Iqbal Z
    Int J Pharm; 2014 Oct; 473(1-2):384-94. PubMed ID: 25051112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved oral efficacy of epirubicin through polymeric nanoparticles: pharmacodynamic and toxicological investigations.
    Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
    Drug Deliv; 2016 Oct; 23(8):2990-2997. PubMed ID: 26800371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
    Nasr M; Nafee N; Saad H; Kazem A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
    Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
    Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
    J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved antitumor activity of epirubicin-loaded CXCR4-targeted polymeric nanoparticles in liver cancers.
    Di-Wen S; Pan GZ; Hao L; Zhang J; Xue QZ; Wang P; Yuan QZ
    Int J Pharm; 2016 Mar; 500(1-2):54-61. PubMed ID: 26748365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
    Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
    Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
    Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S
    Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
    He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
    Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery.
    Chang LC; Wu SC; Tsai JW; Yu TJ; Tsai TR
    Int J Pharm; 2009 Jul; 376(1-2):195-203. PubMed ID: 19439169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery.
    Zhang HZ; Li XM; Gao FP; Liu LR; Zhou ZM; Zhang QQ
    Drug Deliv; 2010 Jan; 17(1):48-57. PubMed ID: 22747075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency.
    Zhang T; Zhou S; Hu L; Peng B; Liu Y; Luo X; Liu X; Song Y; Deng Y
    Drug Deliv Transl Res; 2018 Jun; 8(3):602-616. PubMed ID: 29536348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
    Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.